NRAS and melanoma: In contrast, WT31 melanoma is driven by a NRAS mutation resembling a cohort of patients with unmet clinical need, even colonizes the liver after intravenous (i.v.)injection and therefore better reflects the broader metastatic pattern of human patients [33, 34].